» Articles » PMID: 36618417

No NETs No TIME: Crosstalk Between Neutrophil Extracellular Traps and the Tumor Immune Microenvironment

Overview
Journal Front Immunol
Date 2023 Jan 9
PMID 36618417
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor immune microenvironment (TIME) controls tumorigenesis. Neutrophils are important components of TIME and control tumor progression and therapy resistance. Neutrophil extracellular traps (NETs) ejected by activated neutrophils are net-like structures composed of decondensed extracellular chromatin filaments decorated with a plethora of granules as well as cytoplasmic proteins. Many of these harbour post translational modifications. Cancer cells reportedly trigger NET formation, and conversely, NETs alter the TIME and promote tumor cell proliferation and migration. The specific interactions between NETs and TIME and the respective effects on tumor progression are still elusive. In certain tumors, a CD4 T helper (Th) 2 cell-associated TIME induces NETs and exerts immunosuppressive functions programmed death 1 (PD-1)/PD-L1, both associated with poorer prognosis. In other cases, NETs induce the proliferation of Th1 cells, associated with an improved prognosis in cancer. In addition, NETs can drive macrophage polarization and often rely on macrophages to promote cancer cell invasion and metastasis. In turn, macrophages can swiftly clear NETs in an immunologically silent manner. The aim of this review is to summarize the knowledge about the mutual interaction between NETs and TIME and its impact on tumor growth and therapy.

Citing Articles

Integrated multiomics analysis and machine learning refine neutrophil extracellular trap-related molecular subtypes and prognostic models for acute myeloid leukemia.

Zhong F, Yao F, Wang Z, Liu J, Huang B, Wang X Front Immunol. 2025; 16:1558496.

PMID: 40066454 PMC: 11891243. DOI: 10.3389/fimmu.2025.1558496.


Neutrophil extracellular traps impede cancer metastatic seeding via protease-activated receptor 2-mediated downregulation of phagocytic checkpoint CD24.

Liu Y, Ma J, Ma Y, Wang B, Wang Y, Yuan J J Immunother Cancer. 2025; 13(2).

PMID: 40010762 PMC: 11865804. DOI: 10.1136/jitc-2024-010813.


[Dual Roles of Neutrophil Extracellular Traps in Lung Cancer: 
Mechanism Exploration and Therapeutic Prospects].

Li C, Peng D, Sun W Zhongguo Fei Ai Za Zhi. 2025; 28(1):63-68.

PMID: 39988441 PMC: 11848645. DOI: 10.3779/j.issn.1009-3419.2025.101.01.


A novel golgi related genes based correlation prognostic index can better predict the prognosis of glioma and responses to immunotherapy.

Zhao B, Xuan R, Yang G, Hu T, Chen Y, Cai L Discov Oncol. 2025; 16(1):212.

PMID: 39976877 PMC: 11842676. DOI: 10.1007/s12672-025-01889-6.


Neutrophil extracellular traps in tumor metabolism and microenvironment.

Liu Z, Dou Y, Lu C, Han R, He Y Biomark Res. 2025; 13(1):12.

PMID: 39849606 PMC: 11756210. DOI: 10.1186/s40364-025-00731-z.


References
1.
Tay R, Richardson E, Toh H . Revisiting the role of CD4 T cells in cancer immunotherapy-new insights into old paradigms. Cancer Gene Ther. 2020; 28(1-2):5-17. PMC: 7886651. DOI: 10.1038/s41417-020-0183-x. View

2.
Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View

3.
Gardner A, Ruffell B . Dendritic Cells and Cancer Immunity. Trends Immunol. 2016; 37(12):855-865. PMC: 5135568. DOI: 10.1016/j.it.2016.09.006. View

4.
Egan K, Cooke N, Kenny D . Living in shear: platelets protect cancer cells from shear induced damage. Clin Exp Metastasis. 2014; 31(6):697-704. DOI: 10.1007/s10585-014-9660-7. View

5.
Albrengues J, Shields M, Ng D, Park C, Ambrico A, Poindexter M . Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science. 2018; 361(6409). PMC: 6777850. DOI: 10.1126/science.aao4227. View